Radiation Oncology
Mirada’s RT solutions add the power of automation and optimization of the RT workflows, with quality tools to accelerate RT cancer care
FLEXIBLE AND CONFIGURABLE SOLUTIONS
We offer flexible and highly configurable software with various licensing and deployment options. Mirada Medical products can integrate seamlessly with your PACs, load images from any scanner, and can be deployed as standalone workstation and thin client solution for remote reporting.
CT Organ-at-Risk (OAR) Contouring
DLCExpert™ takes away the manual effort of delineating and contouring OARs
Automation Powered Workflows
DLCExpert™ comes with a Zero-click platform to add efficiency and time saving, but within your current workflow setup
Registration, Visualization & Editing
RTx’s visualization, registration and editing solutions for image-based workflows and OAR target contouring
Software to Accelerate your Cancer Care
DLCExpert – AI Autocontouring
A Zero-click autocontouring solution for RT clinicians, with the flexibility to choose from an AI Library of structures, covering head and neck, thorax, prostate, and breast. Built using deep learning technology (a branch of AI) to save time and add OAR contouring consistency (learn more about what it means for you...).
RTx – Registration & Visualization
RTx is the product of choice for clinics wanting an independent registration, visualization and contour editing software, away from a time-critical TPS. RTx is not a one size fits all tool. Its registration algorithm is uniquely tailored and supports multiple workflows, from target contouring, adaptive to multi-modal fusion and more.
Embrace:MR
A Zero-click multi Atlas contouring solution, Embrace:MR enables you to autocontour any structure in the body using both Mirada's unique proven multi-Atlas technology, which covers the major anatomical sites, and your own Atlas structures, to ensure your departments contouring preferences are met.
The collaboration between UMC Groningen and Mirada Medical has produced autocontouring models that encode according to consensus guidelines, established by an international panel of experts for organs at risk. These DLCExpert models are now deployed in our routine clinical workflows, forming a key part of our treatment planning for all patients with cancers in the head and neck or prostate regions and helping deliver improved outcomes.Charlotte Brouwer
Medical Physicist
University Medical Center Groningen (UMCG)
